P1vital® Ltd

P1vital® Ltd

Manor House
Howbery Business Park
Wallingford, Oxfordshire
OX10 8BA
UNITED KINGDOM

http://www.p1vital.com/

Dr. Gerard Dawson
Dr. Gerard Dawson

CEO P1vital Ltd


Send E-Mail
Dr. Amy Bilderbeck
Dr. Amy Bilderbeck

Director of Scientific Research


Send E-Mail
Dr. Asad Malik
Dr. Asad Malik

Senior Scientist (MRI)


Send E-Mail
Oliver Schofield
Oliver Schofield

Clinical Project Manager


Send E-Mail
Abigail Abrahams
Abigail Abrahams

Senior Scientist


Send E-Mail
Ailidh Finlayson
Ailidh Finlayson

Scientific Support


Send E-Mail

P1vital® is an innovative Clinical Research Organization specializing in experimental medicine for Central Nervous System (CNS) disorders. We develop and deploy CNS efficacy biomarkers in schizophrenia, cognitive disorders, depression and anxiety, eating disorders, and obesity – with the aim of instigating innovative approaches to, and accelerating, drug research and development. P1vital Products Ltd, affiliated with P1vital Ltd, specialises in providing digital solutions for the pharmaceutical and healthcare sectors to improve the quality, compliance, timeliness and accessibility of eCOA, ePRO, and digital biomarker data collection. Our team has extensive expertise in all aspects of CNS drug discovery and development, including regulatory and compliance expertise. We are also skilled in running multi-centred academic, behavioural, and imaging clinical studies (across all phases) that require subjects with unique phenotypes. We have a strong track record of collaborating with internationally renowned opinion leaders in psychiatry and neuroscience, linked through University hospitals and clinical research facilities worldwide.

P1vital Ltd led the clinical project management of the original PRISM project and will continue this legacy in leading WP03 (Clinical study implementation and operations) for the PRISM 2 project. We also contribute to WP2 (Data management, sustainability, and analysis) and WP5 (Ethics and engagement with regulatory groups, agencies, and other stakeholders).

Follow us on social media:
Facebook Twitter